INTERVENTION SPECIFICATIONS. Intervention Specification: Classify Asthma Severity Desired Action:Record asthma symptom frequency and other information.

Slides:



Advertisements
Similar presentations
CDM Registry Project Dr. Richard Lewanczuk Regional Medical Director Chronic Disease Management Capital Health.
Advertisements

What is an asthma registry? n A list of patients with asthma n A source of data for asthma management  individual patient level  individual provider.
Next Throughout this demo, if nothing happens for a couple of seconds click ‘Next’ to continue … SCI Gateway Product Demonstration Updated next.
2012 UPDATE. What guidelines do we have available to follow for asthma 1) Asthma GP monitoring Guideline 2) Asthma Diagnosis Guideline 3) Acute asthma.
Falls Risk Assessment and Management Plan (FRAMP).
Using EMR Templates to Measure Quality of Care for Children with ADHD and Obesity Jeanne Van Cleave, MD Timothy G. Ferris, MD, MPH September 26, 2007.
Learning objectives:- 1. Introduction. 2. Define health record. 3. Explain types of health record. 4. Mention purposes of health record. 5. List general.
DEVELOPER SPECIFICATIONS. Developer Specification: Record Triggers and Environmental Control Factors CIS Application Affected: CentricityIntervention.
Cancer Program Standards 2012: Ensuring Patient-Centered Care
Behavioral Health Services for Injured or Ill workers – Collaborative Care Analysis and Recommendations January 22, 2015.
1 Integrated Multi-Level Approaches to Asthma Management Noreen M. Clark, Ph.D. Dean & Marshall H. Becker Professor University of Michigan School of Public.
PAIN ASSESSMENT PURPOSE  To provide guidelines for the appropriate identification and assessment of patients who may experience pain.
Promoting Excellence in Family Medicine Enabling Patients to Access Electronic Health Records Guidance for Health Professionals.
Improving Collection of HIV Exposure in ARIES September 29, 2011.
2014 NURSES LEADING THE WAY TO IMPROVE ASTHMA OUTCOMES BARBARA MC DONAGH RN ASTHMA CLINIC FANTUS CLINIC CCHHS.
2015 User Conference How Care Plans Impact your Practice OP User Conference 2015 Presented by: Rena Lefkowitz PA-C Director of Training EHR Session.
Decision Support for Quality Improvement
Update on standards for ICPs for mental health Name.
A PLAN TO IMPROVE ASTHMA CARE
Power B, McQuoid P, Caldwell NA, Clareburt A. Pharmacy Department, Wirral Hospital NHS Trust, Wirral. Poster Layout & Design By Wirral Medical Illustration.
National Support Team: Findings from the first 2 years Katrina Stephens Associate Delivery Manager, Alcohol Harm Reduction National Support Team, Department.
Team Membership Dee Kaupie RCP, AE-C Sandy Swanson, RN Michael Wall, PharmD Kathleen Webster, MD Children's Asthma Care Core Measures Confidential: For.
Clinical Care Improvement System Mark Murray, MD, MPA Mark Murray & Associates.
Impact of the “Asthma Toolbox” for Improving Documentation of Pediatric Asthma Management in an Urban Community Health Center Presenter: Delaney Gracy,
Influenza Vaccination Campaign 2003 Dr. Michael Koller QI Director for Primary Care.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
1 Asthma October 30, Weiss, Gergen, & Hodgson (1992)2 Pediatric Statistics Prevalence increasing School absences Estimated as more than 10 million.
Integrated Risk Management Charles Yoe, PhD Institute for Water Resources 2009.
The Chronic Care Model in CQN System Framework for Great Asthma Care.
Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.
System Changes and Interventions: Registry as a Clinical Practice Tool Mike Hindmarsh Improving Chronic Illness Care, a national program of the Robert.
Managed Care. In the broadest terms, Kongstvedt (1997) describes managed care as a system of healthcare delivery that tries to manage the cost of healthcare,
Getting Published Gavin Leslie Judy Currey Andrea Marshall Leanne Aitken.
CHAPTER 28 Translation of Evidence into Nursing Practice: Evidence, Clinical practice guidelines and Automated Implementation Tools.
0 eCPIC Admin Training: OMB Submission Packages and Annual Submissions These training materials are owned by the Federal Government. They can be used or.
Implementing NICE guidance 2011 NICE clinical guideline 113 Generalised anxiety disorder in adults.
National Strategy for Quality Improvement in Health Care June 15, 2011 Kana Enomoto Director Office of Policy, Planning, and Innovation.
Asthma A Presentation on Asthma Management and Prevention.
Asthma Management and the Allergist: Better Outcomes at Lower Cost.
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Developing evidence-based guidelines at WHO. Evidence-based guidelines at WHO | January 17, |2 |
Abstract Title of Poster Authors Department / Division, Advocate Children’s Hospital Title of Poster Authors Department / Division, Advocate Children’s.
Data Driven Clinical Engagement. © Cerner Corporation. All rights reserved. This document contains Cerner confidential and/or proprietary information.
Practice Key Driver Diagram. Chapter Quality Network ADHD Project Jeff Epstein PhD CQN ADHD National Expert/CQN Data Analyst The mehealth Portal and CQN.
Using Outcomes and other Assessment Tools to Improve Quality Quality Improvement.
Design and implementation of a web-based patient portal linked to an electronic health record designed to improve medication safety: the Patient Gateway.
SAGE Nick Beard Vice President, IDX Systems Corp..
Canadian Best Practice Recommendations for Stroke Care Recommendation 1: Public Awareness and Patient Education (Updated 2008)
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Asthma in a Nutshell Holger Link, MD. The Complexity of Asthma Immune System Environment Injury and Repair Genes.
RI Asthma Control Program: Comprehensive Asthma Care Julian Rodriguez-Drix Program Manager.
Integrated Asthma Decision Support System Med Info 406 – Winter 2009 Joan Baird Nudrat Hassan James Ellzy.
Clinical Project Meeting NYHQ PPS Delivery System Reform Incentive Payment (DSRIP) Project Implementation Plan Development Asthma (3dii)
Carol A. Miller, MD Professor, Pediatrics UCSF Benioff Children’s Hospital And the Asthma Task Force Team.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
RI Asthma Control Program: Comprehensive Asthma Care
Critical Care Services Pharmacist Royal Manchester Children’s Hospital
1st International Online BioMedical Conference (IOBMC 2015)
Quality Improvement and EBM
Implementation of Clinical Guidelines Author: dr. Martin Rusnák
High-Risk Pediatric Asthma:
A Caregiver’s Perception of Asthma Control in Children
Meeting with EG PHC Ev. underrubrik Förnamn Efternamn.
Presentation transcript:

INTERVENTION SPECIFICATIONS

Intervention Specification: Classify Asthma Severity Desired Action:Record asthma symptom frequency and other information to enable the CDS system to determine Asthma severity, based on a combination of impairment and risk. Workflow Context:This intervention will be performed and recorded for a patient’s first visit to the pediatric specialty clinic. Subsequent visits will capture and revise similar data to determine the patient’s level of Asthma control. Workflow Step:Classify Asthma Severity Specific CDS Intervention/ CIS Application: Logician - Asthma Severity and Control Screens Specific Clinical Goal(s): Improve patient education and empowerment Improve patient satisfaction with care Optimize decision making Prevent errors of omission/ commission Optimize treatment of chronic conditions Improve documentation of care and communication XXXX Baseline Performance: TBD Target Performance:TBD Approach:Documentation using prompts, radio buttons, check boxes and free text for impairment and risk factors. Information will be captured for: cough, wheezing, chest tightness, shortness of breath, nighttime awakenings, SABA use, reduction in school/play/work activities, acute/ER visits, hospitalizations, exacerbations requiring systemic corticosteroids and medication adverse effects. Information will vary slightly for ages 0 thru 4, 5 thru 11 and greater than 12 years of age and determination of asthma severity will operate in accordance with the NHLBI EPR3 Asthma guideline. Clinical Background:Yale’s Pediatric specialty decision support for asthma patients is being updated to incorporate NHLBI EPR3 guidelines for Asthma. Guideline recommendations for determining asthma severity, level of control, treatment step options and treatment plan details are being integrated into current workflows. Variations From Guideline: GLIDES clarified specific gradations of number of acute ER visits and hospitalizations due to Asthma and their linkage to Asthma severity determination. GLIDES links these factors specifically to the severity assessment, and highlights adaptations of the NHLBI guideline in purple font on all screens. Selection Criteria:All new patients with Asthma presenting to the Pediatric specialty clinic. Target Population For Intervention: Pediatric specialty clinic clinicians User interface:Tabular layout, with panels and check-boxes modeled after the NHLBI EPR3 guideline summary and presentations. Severity – Ages 0-4 Severity – Ages 5-11 Severity – Ages >12 Monitoring and Evaluation:LINK TO EVALUATION PLAN Jobs Expected To Be Affected:All users of Centricity/Logician at the Pediatric specialty clinic. Possible Adverse Consequences Of Implementation: Risk of inaccurate classification, limitation of data collection, and clinician “tunnel vision” through inappropriate dependence on computers for decision support. Primary Stakeholder(s)All clinicians practicing at the Pediatric specialty clinic. Clinical Champion(s):Dr. Alia Bazzy-Asaad Tina Tolomeo Required Delivery DateImplementation is required for October 2008, to ensure experience and feedback can be reported to AHRQ for November 2008

Intervention: Record Triggers and Environmental Control Factors Desired Action:Record additional asthma triggers and environmental control factors. Associated Interventions: This intervention will be performed and recorded for a patient’s subsequent visits to the specialty clinic, to capture and revise information to determine the patient’s level of Asthma control. Workflow Step:Asthma Triggers and Environmental Control Specific CDS Intervention/ CIS Application: Logician - Asthma Severity and Control Screens Specific Clinical Goal(s): Improve patient education and empowerment Improve patient satisfaction with care Optimize decision making Prevent errors of ommission/ commission Optimize treatment of chronic conditions Improve documentation of care and communication XX Baseline Performance: TBD Desired Outcome: TBD Approach:Data Capture using prompting and check boxes for asthma triggers and environmental control factors. Trigger information will be captured for UR1, tobacco, emotional stress, dust, vacuuming, humidity, heat, exercise, pets, weather, mold and cold air. Environmental control information will be captured for smoke, dust, vacuuming, pets, drafts, weather, etc. Clinical Background: Yale’s Pediatric specialty clinic workflows for asthma patients are being updated to incorporate NHLBI EPR3 guidelines for Asthma, as part of the GLIDES project. Guideline recommendations for determining asthma severity, level of control, treatment step options and treatment plan details are being integrated into current workflows. Variations From Guideline: No variations from guidelines. Selection Criteria:All new patients with Asthma presenting to the Pediatric specialty clinic. Target Population For Intervention:Pediatric specialty clinic clinicians Target Population for Intervention: All visitors presenting to the Pediatric specialty clinic with Asthma symptoms. User interface:Tabular layout, with panels and check-boxes modeled after the NHLBI EPR3 guideline summary and presentations. Record Triggers/Controls Monitoring and Evaluation: LINK TO EVALUATION PLAN Jobs Expected To Be Affected: All users of Centricity/Logician at the Pediatric specialty clinic. Possible Adverse Consequences Of Implementation: Risk of inaccurate classification, limitation of data collection, and clinician “tunnel vision” through inappropriate dependence on computers for decision support. Primary Stakeholder(s) All clinicians practicing at the Pediatric specialty clinic. Clinical Champion(s):Dr. Alia Bazzy-Asaad Tina Tolomeo

Intervention: Classify Asthma Control Desired Action:Update asthma symptom frequency and other information to enable the CDS system to determine the level of Asthma control, based on a combination of impairment and risk. Workflow Context:This intervention will be performed and recorded for a patient’s follow-up visits to the pediatric specialty clinic. On their first visit, the patient’s Asthma severity will have been assessed and recorded using a similar data capture and algorithm approach. Workflow Step:Classify Asthma Control Specific CDS Intervention/ CIS Application: Logician - Asthma Severity and Control Screens Specific Clinical Goal(s): Improve patient education and empowerment Improve patient satisfaction with care Optimize decision making Prevent errors of omission/ commission Optimize treatment of chronic conditions Improve documentation of care and communication XXXX Baseline Performance: TBD Desired Outcome: TBD Approach:Data Capture using prompting and check boxes for impairment and risk factors. Information will be captured for: cough, wheezing, chest tightness, shortness of breath, nighttime awakenings, SABA use, reduction in school/play/work activities, acute/ER visits, hospitalizations, exacerbations requiring systemic corticosteroids and medication adverse effects. Information will vary slightly for ages 0 thru 4, 5 thru 11 and greater than 12 years of age and determination of asthma severity will operate in accordance with the NHLBI EPR3 Asthma guideline. Clinical Background: Yale’s Pediatric specialty decision support for asthma patients is being updated to incorporate NHLBI EPR3 guidelines for Asthma. Guideline recommendations for determining asthma severity, level of control, treatment step options and treatment plan details are being integrated into current workflows. Variations From Guideline: GLIDES clarified specific gradations of number of acute ER visits and hospitalizations due to Asthma and their linkage to Asthma control determination. GLIDES links these factors specifically to the severity assessment, and highlights changes to the NHLBI guideline in purple font on all screens. Selection Criteria:All follow-up patients with Asthma presenting to the Pediatric specialty clinic. Target Population For Intervention:Pediatric specialty clinic clinicians User interface:Tabular layout, with panels and check-boxes modeled after the NHLBI EPR3 guideline summary and presentations. Control – Ages 0-4 Control – Ages 5-11 Control – Ages >12 Monitoring and Evaluation: LINK TO EVALUATION PLAN Jobs Expected To Be Affected: All users of Centricity/Logician at the Pediatric specialty clinic. Possible Adverse Consequences Of Implementation: Risk of inaccurate classification, limitation of data collection, and clinician “tunnel vision” through inappropriate dependence on computers for decision support. Primary Stakeholder(s) All clinicians practicing at the Pediatric specialty clinic. Clinical Champion(s):Dr. Alia Bazzy-Asaad Tina Tolomeo Required Delivery Date Implementation is required for October 2008, to ensure experience and feedback can be reported to AHRQ for November 2008

Intervention: Assess Asthma Severity and Control Desired Action:Review the decision support logic’s determination of asthma severity and control, which is based on the results of prior data capture and the NHLBI guidelines. Enable the clinician to either select this recommendation or record an alternative assessment of severity and control, reflecting additional contributing factors Workflow Context:This intervention will be performed and recorded for all patient’s visits to the pediatric specialty clinic. Slight variations to processing logic for first-time and follow-up visits. Workflow Step:Assess Asthma Severity/Control Specific CDS Intervention/ CIS Application: Logician - Asthma Severity and Control Screens Specific Clinical Goal(s): Improve patient education and empowerment Improve patient satisfaction with care Optimize decision making Prevent errors of omission/ commission Optimize treatment of chronic conditions Improve documentation of care and communication XXXX Baseline Performance: TBD Desired Outcome: TBD Approach:Data Capture using radio buttons for severity and control assessment factors and free text for comments and explanations of variance. Information will vary slightly for ages 0 thru 4, 5 thru 11 and greater than 12 years of age and determination of asthma severity will operate in accordance with the NHLBI EPR3 Asthma guideline. Clinical Background: Yale’s Pediatric specialty decision support for asthma patients is being updated to incorporate NHLBI EPR3 guidelines for Asthma. Guideline recommendations for determining asthma severity, level of control, treatment step options and treatment plan details are being integrated into current workflows. Variations From Guideline: The NHLBI logic for determining asthma severity and control levels will be used to present the systems assessment to the clinician. However, the system will also enable the clinician to override this assessment in cases where there are clear variations between the guideline’s determination and the patient’s actual level of asthma severity and control. Selection Criteria:All patients with Asthma presenting to the Pediatric specialty clinic. Target Population For Intervention:Pediatric specialty clinic clinicians User interface:Tables, radio buttons and comment capture windows, an enhancement to existing Logician Asthma screens. Assessment/First Visit Assessment/Follow-Up Visit Monitoring and Evaluation: LINK TO EVALUATION PLAN Jobs Expected To Be Affected: All users of Centricity/Logician at the Pediatric specialty clinic. Possible Adverse Consequences Of Implementation: Risk of inaccurate classification, limitation of data collection, and clinician “tunnel vision” through inappropriate dependence on computers for decision support. Primary Stakeholder(s) All clinicians practicing at the Pediatric specialty clinic. Clinical Champion(s):Dr. Alia Bazzy-Asaad Tina Tolomeo Required Delivery Date Implementation is required for October 2008, to ensure experience and feedback can be reported to AHRQ for November 2008

Intervention: Select Asthma Treatment Step/Plan Desired Action:Present appropriate steps for treatment of Asthma, based on previously determined severity and control information, and enable clinicians to select and initiate a treatment plan, or to adjust a prior treatment step/plan. Associated Interventions: This intervention will be performed and recorded for a patient’s first visit to the pediatric specialty clinic as well as subsequent visits. Workflow Step: Select Asthma Treatment Step Specific CDS Intervention/ CIS Application: Logician - Asthma Severity and Control Screens Specific Clinical Goal(s): Improve patient education and empowerment Improve patient satisfaction with care Optimize decision makingPrevent errors of omission/ commission Optimize treatment of chronic conditions XX Baseline Performance: TBD Desired Outcome:TBD Approach:Decision support using presentation of Asthma treatment step options and selection by the clinician of an appropriate plan. Treatment step information will vary slightly for ages 0-4, 5-11 and greater than 12 years of age. Clinical Background: Yale’s Pediatric specialty clinic workflows for asthma patients are being updated to incorporate NHLBI EPR3 guidelines for Asthma, as part of the GLIDES project. Guideline recommendations for determining asthma severity, level of control, treatment step options and treatment plan details are being integrated into current workflows. Variations From Guideline: Clinicians will be informed through an exception message if their selected treatment step differs from the NHLBI EPR3 Asthma guideline recommendations. Clinicians will be asked to document their reasons for variance. Selection Criteria:All patients with Asthma presenting to the Pediatric specialty clinic. Target Population For Intervention: Pediatric specialty clinic clinicians User interface:Charts and radio buttons, modeled after the NHLBI EPR3 Asthma guideline treatment plan, with comment boxes to enable variance selections to be documented. Steps – Ages 0-4 Steps – Ages 5-11 Steps – Ages >12 Monitoring and Evaluation: LINK TO EVALUATION PLAN Jobs Expected To Be Affected: All users of Centricity/Logician at the Pediatric specialty clinic. Possible Adverse Consequences Of Implementation: Risk of inaccurate classification, limitation of data collection, and clinician “tunnel vision” through inappropriate dependence on computers for decision support. Primary Stakeholder(s) All clinicians practicing at the Pediatric specialty clinic.Clinical Champion(s): Dr. Alia Bazzy-Asaad Tina Tolomeo Required Delivery Date Implementation is required for October 2008, to ensure experience and feedback can be reported to AHRQ for November 2008